期刊文献+

米索前列醇用于预防经阴道自然分娩产后出血的临床分析 被引量:8

Clinical analysis of misoprostol for the prevention of postpartum hemorrhage induced by transvaginal natural delivery
下载PDF
导出
摘要 目的:探讨米索前列醇预防经阴道自然分娩产后出血的临床疗效以及不良反应。方法:将100例自然分娩产妇按随机数列法分为对照组与观察组,每组50例。观察组采用米索前列醇片治疗,对照组采用缩宫素治疗。对比两组产后24 h出血量、产后出血发生率、宫腔积血发生率与不良反应发生率。结果:两组产后24 h出血量、宫腔积血发生率、不良反应发生率均存在显著差异,差异具有统计学意义(P<0.05)。结论:米索前列醇预防经阴道自然分娩产后出血疗效确切,能够明显降低患者产后出血量,降低术后不良反应。 Objective:To explore the clinical curative effect and adverse reactions of misoprostol for the prevention of postpartum hemorrhage induced by transvaginal natural delivery.Methods:According to random sequence method,100 cases of puerpera with natural delivery were divided into the control group and the observation group,with 50 cases in each group.The observation group were treated with misoprostol tablets and the control group were treated with oxytocin.The postpartum 24 h blood loss,incidence of postpartum hemorrhage,uterine hemorrhage rate and incidence of adverse reactions of the two groups were compared.Results:There were statistically significant differences of the postpartum 24 h blood loss,uterine hemorrhage rate and incidence of adverse reactions between the two groups(P<0.05).Conclusion:Misoprostol for the prevention of postpartum hemorrhage induced by transvaginal natural delivery had curative effect,which could reduce the postpartum haemorrhage amount of patients significantly and reduce the postoperative adverse reactions.
作者 陈爱莲
出处 《中国社区医师》 2015年第16期52-53,共2页 Chinese Community Doctors
关键词 米索前列醇 经阴道 自然分娩 产后出血 不良反应 Misoprostol Transvaginal Natural delivery Postpartum hemorrhage Adverse reactions
  • 相关文献

参考文献5

二级参考文献31

  • 1唐秋英,周红生,张红君,周丽华.米索前列醇用于预防产后出血的临床探讨[J].中国妇产科临床杂志,2003,4(5):363-365. 被引量:7
  • 2王菊英.米索前列醇在预防剖宫产术后出血中的应用[J].中国妇幼保健,2004,19(7):55-56. 被引量:1
  • 3康义华,周清莲.分娩后静脉推注缩宫素致过敏性休克[J].药物不良反应杂志,2005,7(1):36-36. 被引量:8
  • 4Soares DV.Clinical,laboratory and therapeuties aspects of sheehan's sydrome[J].Arq Bras Endocrinal Metabol,2008,52(5):872-878.
  • 5Janice M,Erson MD.Pretention and management of postpartum Hemorrhage[J].Am Fain Physician,2007,75(6):875.
  • 6Khan RU,Ei-Refaey H.Pharnacokinetics and adverse-effect profile of rectally administered misoprestol in the third stage of labor[J].Obstet Gynecol,2003,101(5pt1):968-974.
  • 7Chelmow D.Postpartum haemorrhage:prevetion[J].Clin Evid:Online,2008,35:1410.
  • 8Zieman M, Fong SK, Benowitz NL, et al. Absorption kinetics of miso- prostol with oral or vaginal administration[J].Obstet Gynecol, 1997, 90 (1): 88.
  • 9Tang OS, Schweer H, Seyberth HW, et al. Pharmacokinetics of differ- ent routes of administration of misoprostol[J].Hum Reprod, 2002, 17 (2): 332.
  • 10Khan R, El - Refaey H, Sharma S, et al. Oral, rectal and vaginal pharmacokinetics of misoprostol [J]. Obstet Gynaecol, 2004, 103 (5) : 866.

共引文献80

同被引文献49

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部